VIDAS® TBI Real Life Performance in Subjects with Mild Traumatic Brain Injury (mTBI)

NARecruitingINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

June 16, 2025

Study Completion Date

November 16, 2025

Conditions
Mild Traumatic Brain Injury
Interventions
DIAGNOSTIC_TEST

VIDAS® TBI Test [GFAP and UCH-L1 assays]

The VIDAS® TBI (GFAP, UCH-L1) test is composed of two automated assays - VIDAS® TBI (GFAP) and VIDAS® TBI (UCH-L1) - to be used on the VIDAS® family of instruments for the quantitative measurement of Glial 15 Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase- L1 (UCH-L1) in human serum using the Enzyme Linked Fluorescent Assay (ELFA) technique. The results of both assays are required to obtain an overall qualitative test interpretation.

Trial Locations (5)

14627

RECRUITING

University of Rochester, Rochester

32806

RECRUITING

Orlando Health, Orlando

48202

RECRUITING

Wayne State University, Detroit

55905

RECRUITING

Mayo Clinic, Rochester

63130

RECRUITING

Washington University, St Louis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioMérieux

INDUSTRY